CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Discover credit cards that provide cash rewards without annual fees. Make your spending count!
26,108 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Ethereum tests a critical juncture, slipping toward $2,000 as bears push below a key resistance zone. The move fuels ...
Banks and insurers are watching a quiet 2026 hurricane season closely, warning that storm risk remains a factor for h...
A new wave of personal AI assistants promises to act before you ask, with Town leading a $55 million round to connect...
Anthropic's public listing signals a new wave of AI investment. This piece highlights which major tech names could ri...
XRP is testing the $1 threshold as ETF inflows stall after a weeks-long surge. This price analysis evaluates implicat...
The EUAD ETF has rebounded, prompting investors to focus on three defense stocks to watch as European budgets firm up...
SMH investors are entering a pivotal July earnings season, with hyperscaler capex guidance set to determine the ETF's...
Anthropic will now publicly flag when its most capable AI downgrades or rejects requests for safety or national secur...
Anthropic moved to disable access to its Fable 5 and Mythos 5 models after a U.S. export controls directive barred fo...
Bitcoin’s iran rally faces a fresh test as macro signals from oil, equities, and Japanese policy converge. Markets we...
Whale activity shows 420,000,000 dogecoin (doge) days: over the past week, fueling a split among traders on whether D...